Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.86 USD | -1.19% | -4.78% | -7.55% |
Apr. 30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
Apr. 30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
Financials (USD)
Sales 2024 * | 712M | Sales 2025 * | 842M | Capitalization | 1.72B |
---|---|---|---|---|---|
Net income 2024 * | 141M | Net income 2025 * | 232M | EV / Sales 2024 * | 2 x |
Net cash position 2024 * | 292M | Net cash position 2025 * | 524M | EV / Sales 2025 * | 1.42 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
7.86
x | Employees | 246 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.66% |
Latest transcript on Harmony Biosciences Holdings, Inc.
1 day | -1.19% | ||
1 week | -4.78% | ||
Current month | -3.40% | ||
1 month | +1.15% | ||
3 months | -11.89% | ||
6 months | +19.01% | ||
Current year | -7.55% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Director of Finance/CFO | 54 | 21-03-28 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 17-07-24 |
R. Graf
BRD | Director/Board Member | 59 | 20-11-10 |
Andreas Wicki
BRD | Director/Board Member | 64 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 14 M€ | -3.61% | ||
0.35% | 28 M€ | -0.48% | ||
0.31% | 25 M€ | -1.82% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 29.86 | -1.19% | 297,234 |
24-05-13 | 30.22 | +0.27% | 270,867 |
24-05-10 | 30.14 | -3.64% | 250,707 |
24-05-09 | 31.28 | -1.32% | 319,020 |
24-05-08 | 31.7 | +1.08% | 453,733 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.55% | 1.72B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- HRMY Stock